Abstract:Molecular chaperones play a key role in maintaining proteostasis and cellular health. The abundant, essential, cytosolic Hsp90 (Heat shock protein, 90 kDa) facilitates the folding and activation of hundreds of newly synthesized or misfolded client proteins in an ATP-dependent folding pathway. In a simplified model, Hsp70 first helps load client onto Hsp90, ATP binding results in conformational changes in Hsp90 that result in the closed complex, and then less defined events result in nucleotide hydrolysis, client release and return to the open state. Cochaperones bind and assist Hsp90 during this process. We previously identified a series of yeast Hsp90 mutants that appear to disrupt either the 'loading', 'closing' or 'reopening' events, and showed that the mutants had differing effects on activity of some clients. Here we used those mutants to dissect Hsp90 and cochaperone interactions. Overexpression or deletion of HCH1 had dramatically opposing effects on the growth of cells expressing different mutants, with a phenotypic shift coinciding with formation of the closed conformation. Hch1 appears to destabilize Hsp90-nucleotide interaction, hindering formation of the closed conformation, whereas Cpr6 counters the effects of Hch1 by stabilizing the closed conformation. Hch1 and the homologous Aha1 share some functions, but the role of Hch1 in inhibiting progression through the early stages of the folding cycle is unique. Sensitivity to the Hsp90 inhibitor NVP-AUY922 also correlates with the conformational cycle, with mutants defective in the loading phase being most sensitive and those defective in the reopening phase being most resistant to the drug. Overall, our results indicate that the timing of transition into and out of the closed conformation is tightly regulated by cochaperones. Further analysis will help elucidate additional steps required for progression through the Hsp90 folding cycle and may lead to new strategies for modulating Hsp90 function. Hsp90 undergoes a series of complex conformational changes as it progresses through the ATP-dependent folding cycle. Using a series of yeast Hsp90 mutants defective at distinct steps, we demonstrate that the Hch1, Aha1 and Cpr6 cochaperones tightly regulate Hsp90 function in vivo, supporting a role as conformational pacemakers of Hsp90. In particular, our results suggest that Hch1 negatively regulates progression through the cycle by reducing Hsp90 interaction with ATP. We also show that sensitivity to Hsp90 inhibitors also correlates with conformation. Our results provide evidence that timing of Hsp90 conformational changes, rather than ATPase activity, is critical, and that cochaperones play an active role in regulating this process.

The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.

Stimulation of the weak ATPase activity of human hsp90 by a client protein

Structural basis for recognition of the Hsp90 closed, ATP state by the TPR‐containing co‐chaperone FKBP51

Ordered ATP hydrolysis in the Hsp90 chaperone is regulated by Aha1 and a conserved post‐translational modification

Conserved conformational changes in the ATPase cycle of human Hsp90

The dynamic triage interplay of Hsp90 with its chaperone cycle and client binding

Structural basis for the dynamic chaperoning of disordered clients by Hsp90

The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones

The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state

Thr90 Phosphorylation of Hsp90α by Protein Kinase A Regulates Its Chaperone Machinery.

Structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client-maturation state

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery

Hsp90 Chaperone Activity Requires the Full-length Protein and Interaction among Its Multiple Domains

Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine

Conformational Dynamics of the Molecular Chaperone Hsp90 in Complexes with a Co-chaperone and Anticancer Drugs

Site‐selectively Phosphorylated Hsp90 C‐terminal Domain Variants Provide Access to Deciphering the Chaperone Code.

A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90

Molecular basis of the interaction of Hsp90 with its co‐chaperone Hop

Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones

Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates

Hsp90 mutants with distinct defects provide novel insights into cochaperone regulation of the folding cycle